Okay, only a small trial, but another ringing endorsement of CYP's Cymerus technology, with ANOTHER fully funded trial. Fully funded trials they can do all day long with little expense thank you. Almost a free option.
The market is mostly ignorant of little CYP, but anyone with a rudimentary bio-tech investment background will know the accolade that a small company life CYP having two fully funded university trials is, and yes, trials take time - pfft!
(thank you whoever sold me that small $0.285 parcel, I am there for a good bit more if you'd like to sell some more).
Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $40.67M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $29.91K | 170.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35924 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 27622 | 2 |
View Market Depth
| Last trade - 15.57pm 28/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |